Davis Polk advised L Brands, Inc. in connection with its $1 billion amended and restated secured revolving credit facility. This new facility replaces an existing $1 billion secured revolving credit facility, and includes a right for certain of L Brands’ non-U.S. subsidiaries to borrow and obtain letters of credit, which borrowings and letters of credit will be guaranteed by L Brands and its material U.S. subsidiaries, and a right for L Brands to increase the commitments under the facility by $500 million subject to the consent of the lenders providing such additional commitments. Under the new facility L Brands and certain of such foreign subsidiaries may borrow and obtain letters of credit in U.S. dollars and, subject to specified limitations as to the amount of each such currency, Canadian dollars and pounds sterling, and, subject to the consent of the relevant lenders, to add additional currencies and subsidiary borrowers.
Covington Advises AstraZeneca on Strategic Transaction with Almirall in Respiratory Disease
Covington & Burling advised AstraZeneca on its agreement to transfer to the company the rights to Almirall’s respiratory franchise for an initial consideration of $875 million on completion, and up to $1.22 billion in development, launch, and sales-related milestones. AstraZeneca has also agreed to make various sales-related payments.
More >>
Willkie Advises GFI Group and GFI Management Group on Strategic Transactions with CME Group Valued at $820 Million
On July 30, it was announced that Willkie client GFI Group Inc., a leading intermediary and provider of trading technologies and support services to the global OTC and listed markets, entered into definitive agreements with CME Group, the world’s leading and most diverse derivatives marketplace, to create value for their respective stockholders through a two-step transaction. The total deal value is approximately $820 million including outstanding debt. In the first step, CME Group will acquire the Trayport and FENICS subsidiaries of GFI Group by first acquiring all of the outstanding shares of GFI Group in exchange for $4.55 per share in CME Group Class A Common Stock.
Tags: Willkie Farr & Gallagher LLP 
Shearman & Sterling Advises Lead Arrangers on $5 Billion Financing for Abbott Laboratories
Shearman & Sterling advised Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays Bank Plc, J.P. Morgan Securities LLC and Morgan Stanley Senior Funding, Inc. as joint lead arrangers and joint bookrunners in connection with a $5 billion five-year credit facility for Abbott Laboratories. The Shearman & Sterling team included partner Maura O’Sullivan (New York-Finance), counsel Susan Hobart (New York-Finance) and associate Spencer Barrowes (New York-Finance).
More >>
DLA Piper Advises on $1.65 Billion Nigerian Oil and Gas Acquisition
DLA Piper has advised Oando, the Nigeria-based integrated energy solutions provider, on the $1.65 billion acquisition of ConocoPhillips’ offshore and onshore assets in Nigeria and the associated reserve-based, multi-source financing.
This acquisition will make Oando one of the largest indigenous oil producers both in Nigeria and Africa as a whole.
Tags: DLA Piper
Drew & Napier acted for Swissco Holdings Limited’s proposed acquisition of Scott and English Energy Pte. Ltd. for a purchase consideration of S$285 million
Drew & Napier is acted for Swissco Holdings Limited, in relation to its proposed acquisition of Scott and English Energy Pte. Ltd., a fast-growing international rig owner, for a purchase consideration of S$285 million to be satisfied by the allotment and issue of shares in Swissco Holdings Limited.
Tags: Drew & Napier LLC
Kirkland & Ellis Represents Pfizer in $635M Acquisition of Baxter Vaccine Portfolio
Kirkland & Ellis LLP represented Pfizer Inc. in its definitive agreement announced today to acquire Baxter International Inc.’s portfolio of marketed vaccines for $635 million. As part of the transaction, Pfizer will also acquire a portion of Baxter’s facility in Orth, Austria, where these vaccines are manufactured. Baxter’s portfolio of marketed vaccines consists of NeisVac-C and FSME-IMMUN/TicoVac. The transaction is subject to customary closing conditions as well as regulatory approvals in several markets, including some countries in the European Union, and is expected to occur by the end of 2014.
Tags: Kirkland & Ellis LLP Macfarlanes advises on £350m refinancing of Legal & General’s Industrial Property Investment Fund
Macfarlanes has advised the Industrial Property Investment Fund, the largest industrial property fund in the UK, on a £350m refinancing deal. The fund is managed by Legal & General Property.
Tags: Macfarlanes LLP
Milbank Represents Underwriters in $500 million first time Basel III Tier 2 Bond Offering by Brazil’s Caixa Econômica Federal
Milbank, Tweed, Hadley & McCloy LLP represented the underwriters BB Securities Ltd., Banco Bradesco BBI S.A., Banco BTG Pactual S.A. – Cayman Branch, Deutsche Bank Securities Inc., HSBC Securities (USA) Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated in the $500 million offering of 7.250% notes due July 2024 by Caixa Econômica Federal.
Tags: Milbank LLP | Sao PauloShearman & Sterling Advises on eBay $3.5 Billion Registered Bond Offering
Shearman & Sterling represented the underwriters, led by Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC, in connection with eBay Inc.’s registered public offering of $3.5 billion aggregate principal amount of investment grade Notes, comprised of $450 Million of Floating Rate Notes due 2017, $400 million of Floating Rate Notes due 2019, $1.15 billion of 2.200% Notes due 2019, $750 million of 2.875% Notes due 2021 and $750 million of 3.450% Notes due 2024.
Tags: Shearman & Sterling LLP 